We warn of potential downside risk for Palo Alto Networks (PANW) stock due to high expectations and bearish outlook in the ...
Trial Met the Primary Endpoint and Provides Evidence of GTx-104 Clinical Benefit Compared to Orally Administered Nimodipine New Drug Application (NDA) Submission Expected in the First Half of 2025 PRI ...
Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25. If approved, FILSPARI could be the first and only approv ...
Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25 If approved, FILSPARI could be the first and only approved medicine indicated ...
Sequoia Holdings, LLC, founded in 2012, is an award-winning employee-owned provider of high-end software development and engineering services focused on enhancing data analysis, collection, ...
Q1 2025 Earnings Call Transcript February 10, 2025 Operator: Greetings. Welcome to CSPi’s First Quarter Fiscal Year 2025 Conference Call. [Operator Instructions] Please note, this conference is being ...
Accelsiustm, a leader in innovative two-phase, direct-to-chip cooling technology, today announced a strategic partnership with Nordik Data Centers to build a next-generation AI data center near ...
Navigator Medicines, Inc., a clinical-stage biotech company leading the advancement of biologics for targeted immune regulation and restoration, today announced the appointments of Tausif (?Tosh') ...
21hon MSN
The byline explores 5G edge opportunities, security challenges, and safeguarding strategies for digital innovation.
Virtual Workspace Solution Market to USD 64 bn by 2034, will be driven by a 13.5% CAGR, highlighting opportunities for ...
The following highlights showcase the most pivotal, innovative research published across multiple therapeutic areas in ...
Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), today announced that the US Food and Drug Administration (FDA) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results